Connect with us

Hemp Industry Updates

Colombian Cannabis Producer, PharmaCielo, Successfully Exports CBD to Switzerland

Published

on

Colombian Cannabis Producer, PharmaCielo, Successfully Exports CBD to Switzerland

Columbia’s first CBD export has been completed and this has successfully reached in Switzerland reports news outlet, Grizzle. The company to have achieved this with the approval from the Colombian government is PharmaCielo, which received the necessary licenses as early as a month ago. The exported cannabis was sent to Cresco Pharma’s Swiss branch.

CEO of PharmaCielo, David Attard expressed the completion of the exports as being “symbolic on many levels.” He further voiced the nature of the firm, adding that it is the first-ever medical cannabis company in Columbia to have done so. Attard appears to be happy by this, especially that the company was able to send goods to Cresco Pharma, where the latter is described as a “trusted partner soon to be part of [PharmaCielo].”

Headquartered in Ontario, Canada, PharmaCielo has also signed sales agreements with other businesses situated in Uruguay, Paraguay, Bolivia and Southern Brazil, with plans to extend its goods all across Europe with the help of distributions firm, Laboratorios Adler.

Catherine is one of our most respected contributors and active providers of cannabis-related guides and insights here at TOC. She is very well educated with a Bachelors from Smith College, Master’s Degree from the University of Arizona, Certificate in Computer Programming College of Saint Rose and was a writing teacher at the University of Illinois. Her writing has been featured in many major publications and has full intentions of being a transparent and authentic leader for all CBD and hemp oil articles.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.